Nihon Medical Center
Corporate Profile
Book Information
Journal Information
Clinical Gastroenterology
The Japanese Journal of Clinical Dialysis
INTESTINE
Kidny and Metabolic Bone Diseases
Title Search Online
Sample Pages for iPad
Clinical Gastroenterology Vol.31 No.07 ( Jun, 2016)
Chemotherapy for Gastro-intestinal Cancer
Purchase an e-book [isyo.jp]
Thesis List
0
Editorial
Junji Furuse
1
Cancer Chemotherapy : Standard Therapy & Clinical Trial
Hiroshi Ishii
2
Imaging-based Evaluation for Tumor Response to Treatment, But Not for Decisions on Its Continuation
Hiroaki Onaya
3
Chemotherapy for Senior Adult
Kirio Kawai
4
Drug Resistance in Cancer Chemotherapy
Hirofumi Nakayama
5
Molecular Targeted Therapy in Digestive Cancer
Hiromichi Ebi
6
Complications of Gastroenterological Cancer and Chemotherapy : Gastrointestinal Obstruction and Perforation Obstruction of the Bile Duct
Masao Toki
7
Chemotherapy for Cancer Patients with Hepatic or Renal Dysfunction
Shunichiro Iwasawa
8
Countermeasures for Reactivation of Hepatitis B Virus by Chemotherapy
Masafumi Ikeda
9
Management of Bone Metastasis with BMA in Patients with Gastrointestinal Cancer
Haruo Iguchi
10
Medications for Palliative Care
Etsuko Aruga
11
Psychological and Psychiatric Interventions for the Distress in Cancer Treatment
Asao Ogawa
12
Issues around Chemotherapy from the Health-care Economic Standpoint
Koichi Kawabuchi
13
Risk Management of Cancer Chemotherapy
Keigo Komine
14
Perspective of Systemic Chemotherapy for Gastrointestinal Malignancy
Narikazu Boku
15
Concept of Neoadjuvant and Adjuvant Therapy for Patients with Gastroenterological Cancer
Masaki Nakamura
16
Role of Radiotherapy for Gastrointestinal Cancers
Yoshinori Ito
17
Immunotherapy for Gastrointestinal Cancer:Evidence and Expectations
Tetsuya Nakatsura
18-1
Fluoropyrimidines
Makoto Ueno
18-2
Fundamental Knowledge of Platinum-based Drugs
Naohiro Okano
18-3
Taxans
Seigo Yukisawa
18-4
Irinotecan
Masato Ozaka
18-5
Gemcitabine
Kentaro Sudo
18-6
Angiogenesis Inhibitors:Bevacizumab and Ramucirumab
Hiroki Yoshita
18-7
Kinase-inhibiting Drugs : Imatinib, Sorafenib, Sunitinib, Regorafenib
Hiroyuki Arai
18-8
Anti-EGFR Antibody and Anti-HER2 Antibody
Shinichiro Taira
18-9
Octreotide
Satoshi Shimizu
18-10
Everolimus
Yasushi Kojima
18-11
Streptozocin, Etoposide, Lonsurf
Michitaka Nagase
19-1
Esophageal Cancer
Hidekazu Hirano
19-2
Current Standard Chemotherapy in Metastatic Gastric Cancer
Yoshiki Horie
19-3
Adjuvant and Neoadjuvant Chemotherapy for Gastric Cancer
Keiichi Fujiya
19-4
Colorectal Cancer : Unresectable and Recurrence
Hiromi Imataka
19-5
Evidence-based Adjuvant Chemotherapy for Colorectal Cancer
Yuka Tamaoki
19-6
Chemotherapy for Hepatocellular Carcinoma
Tatsuya Yamashita
19-7
Systemic Chemotherapy for Biliary Tract Cancer
Masayuki Furukawa
19-8
Recent Progress in Pancreatic Cancer
Mitsuhito Sasaki
19-9
Small Intestinal Tumor
Satoshi Komiyama
19-10
Pharmacotherapies of Gastroenteropancreatic Neuroendocrine Neoplasms
Keijiro Ueda
19-11
Small Intestinal Tumor
Tetsuhito Muranaka
19-12
Gastrointestinal Lymphoma
Masahiro Yokoyama
20-1
Myelosuppression
Yukio Yoshida
20-2
Management Techniques of Side Effects -- Gastrointestinal Disorders
Nozomi Okuno
20-3
Neuropathy : Chemotherapy‒induced Peripheral Neuropathy and Leukoencephalopathy
Daisuke Naruge
20-4
Skin Disorder and Edema
Mikiko Tohyama
20-5
Interstitial Lung Disease
Takashi Ogura
20-6
Hepatic Disorder, Renal Disorder
Eiichiro Suzuki
20-7
Cardiovascular Complications of Chemotherapy and its Monitoring
Hideaki Yoshino
20-8
Infusion Reaction
Shigeatsu Motoori